SOLUZIONE GLUCOSATA 25% CON METIONINA  PIRAMAL Italia - italiano - Ministero della Salute

soluzione glucosata 25% con metionina piramal

piramal critical care italia s.p.a. - glucosio, acetilmetionina - glucosio - 275 g; acetilmetionina - 50 g - combinations

RITMODAN Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ritmodan

cheplapharm arzneimittel gmbh - disopiramide - disopiramide

RITMODAN RETARD Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ritmodan retard

cheplapharm arzneimittel gmbh - disopiramide - disopiramide

SUNITINIB PIRAMAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

sunitinib piramal

piramal critical care italia s.p.a. - sunitinib - sunitinib

LENALIDOMIDE PIRAMAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

lenalidomide piramal

piramal critical care italia s.p.a. - lenalidomide - lenalidomide

ICATIBANT PIRAMAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

icatibant piramal

piramal critical care italia s.p.a. - icatibant - icatibant

Lonsurf Unione Europea - italiano - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridina, tipiracil hydrochloride - neoplasie colorettali - agenti antineoplastici - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Lonsurf 15 mg/6.14 mg compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

lonsurf 15 mg/6.14 mg compresse rivestite con film

servier (suisse) sa - trifluridinum, tipiracilum - compresse rivestite con film - trifluridinum 15 mg, tipiracilum 6.14 mg ut tipiracili hydrochloridum, lactosum monohydricum 90.735 mg, amylum pregelificatum, acidum stearicum, pellicule: hypromellosum, macrogolum 8000, e 171, magnesii stearas, encre: lacca, e 172 (rubrum), e 172 (flavum), e 171, e 132, cera carnauba, talcum, pro compresso obducto. - cancer colorectal métastatique, cancer gastrique métastatique - synthetika

Lonsurf 20 mg/8.19 mg compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

lonsurf 20 mg/8.19 mg compresse rivestite con film

servier (suisse) sa - trifluridinum, tipiracilum - compresse rivestite con film - trifluridinum 20 mg, tipiracilum 8.19 mg ut tipiracili hydrochloridum, lactosum monohydricum 120.980 mg, amylum pregelificatum, acidum stearicum, pellicule: hypromellosum, macrogolum 8000, e 171, e 172 (rubrum), magnesii stearas, encre: lacca, e 172 (rubrum), e 172 (flavum), e 171, e 132, cera carnauba, talcum, pro compresso obducto. - cancer colorectal métastatique, cancer gastrique métastatique - synthetika

FENTANEST Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

fentanest

piramal critical care italia s.p.a. - fentanil - fentanil